Adiposity and cancer risk: new mechanistic insights from epidemiology

[1]  Iain E. Buchan,et al.  Body mass index relates weight to height differently in women and older adults: serial cross-sectional surveys in England (1992–2011) , 2016, Journal of public health.

[2]  J. Perry,et al.  Evidence of a Causal Association Between Insulinemia and Endometrial Cancer: A Mendelian Randomization Analysis , 2015, Journal of the National Cancer Institute.

[3]  F. Sotgia,et al.  Caveolae and signalling in cancer , 2015, Nature Reviews Cancer.

[4]  Dong Hoon Lee,et al.  Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. , 2015, Journal of the National Cancer Institute.

[5]  F. Bertolini,et al.  Stem cells from adipose tissue and breast cancer: hype, risks and hope , 2015, British Journal of Cancer.

[6]  Gretchen A. Stevens,et al.  Global burden of cancer attributable to high body-mass index in 2012: a population-based study. , 2015, The Lancet. Oncology.

[7]  A. Renehan,et al.  Excess adiposity and gastrointestinal cancer , 2014, The British journal of surgery.

[8]  Shawn W. Polson,et al.  High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity , 2014, Nature.

[9]  K. Bhaskaran,et al.  Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults , 2014, The Lancet.

[10]  C. Abnet,et al.  A Prospective Cohort Study of Body Size and Risk of Head and Neck Cancers in the NIH–AARP Diet and Health Study , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[11]  A. Renehan,et al.  Diabetes and cancer: 5 years into the recent controversy. , 2014, European journal of cancer.

[12]  D. Clegg,et al.  Obesity and cancer—mechanisms underlying tumour progression and recurrence , 2014, Nature Reviews Endocrinology.

[13]  M. Singer,et al.  Metabolic Health Reduces Risk of Obesity-Related Cancer in Framingham Study Adults , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[14]  C. Ulrich,et al.  A Review of the Application of Inflammatory Biomarkers in Epidemiologic Cancer Research , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[15]  I E Buchan,et al.  Slowing down of adult body mass index trend increases in England: a latent class analysis of cross-sectional surveys (1992–2010) , 2014, International Journal of Obesity.

[16]  S. Gapstur,et al.  Waist circumference, body mass index, and postmenopausal breast cancer incidence in the Cancer Prevention Study-II Nutrition Cohort , 2014, Cancer Causes & Control.

[17]  H. Brenner,et al.  GWAS-Identified Common Variants for Obesity Are Not Associated with the Risk of Developing Colorectal Cancer , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[18]  Y. Kanai,et al.  Association of Pancreatic Fatty Infiltration With Pancreatic Ductal Adenocarcinoma , 2014, Clinical and Translational Gastroenterology.

[19]  S. Yusuf,et al.  The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia , 2014, Diabetes Care.

[20]  N. Ohtani.  Microbiome and cancer , 2014, Seminars in Immunopathology.

[21]  T. Buchanan,et al.  HOMA and Matsuda indices of insulin sensitivity: poor correlation with minimal model-based estimates of insulin sensitivity in longitudinal settings , 2014, Diabetologia.

[22]  A. Diehl,et al.  NAFLD, NASH and liver cancer , 2013, Nature Reviews Gastroenterology &Hepatology.

[23]  G. Chrousos,et al.  Circulating leptin levels and risk of colorectal cancer and adenoma: a case–control study and meta-analysis , 2013, Cancer Causes & Control.

[24]  F. Hu,et al.  Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. , 2013, The lancet. Diabetes & endocrinology.

[25]  M. Pike,et al.  Type I and II endometrial cancers: have they different risk factors? , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  A. McTiernan,et al.  Effects of Dietary Weight Loss and Exercise on Insulin-Like Growth Factor-I and Insulin-Like Growth Factor-Binding Protein-3 in Postmenopausal Women: A Randomized Controlled Trial , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[27]  A. Hollenbeck,et al.  Comparison of Associations of Body Mass Index, Abdominal Adiposity, and Risk of Colorectal Cancer in a Large Prospective Cohort Study , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[28]  C. Muller.  Tumour-surrounding adipocytes are active players in breast cancer progression. , 2013, Annales d'endocrinologie.

[29]  J. Chang-Claude,et al.  Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort--a factor analysis. , 2013, American journal of epidemiology.

[30]  E. Giovannucci,et al.  A prospective study of plasma inflammatory markers and risk of colorectal cancer in men , 2013, British Journal of Cancer.

[31]  M. Pike,et al.  Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. , 2013, Endocrine-related cancer.

[32]  Reiko Nishihara,et al.  Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status. , 2013, Cancer research.

[33]  M. VanSaun.  Molecular Pathways Molecular Pathways : Adiponectin and Leptin Signaling in Cancer , 2013 .

[34]  T. Pischon,et al.  Obesity and colorectal cancer. , 2013, Frontiers in bioscience.

[35]  J. Ioannidis,et al.  Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk. , 2012, Journal of the National Cancer Institute.

[36]  M. Zwahlen,et al.  Re: body mass index and risk of lung cancer among never, former, and current smokers. , 2012, Journal of the National Cancer Institute.

[37]  V. Tremaroli,et al.  Functional interactions between the gut microbiota and host metabolism , 2012, Nature.

[38]  R. Goldbohm,et al.  Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis. , 2012, International journal of epidemiology.

[39]  A. Wolk,et al.  Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[40]  Gretchen L. Gierach,et al.  Body mass index and risk of lung cancer among never, former, and current smokers. , 2012, Journal of the National Cancer Institute.

[41]  C. Mantzoros,et al.  The role of adiponectin in cancer: a review of current evidence. , 2012, Endocrine reviews.

[42]  D. Greenwood,et al.  Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[43]  Andy H. Lee,et al.  Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies , 2012, The Lancet. Oncology.

[44]  Andy H. Lee,et al.  Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies , 2012, PLoS medicine.

[45]  J. Meyerhardt,et al.  Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study. , 2012, Journal of the National Cancer Institute.

[46]  J. Olefsky,et al.  The cellular and signaling networks linking the immune system and metabolism in disease , 2012, Nature Medicine.

[47]  M. Pollak.  The insulin and insulin-like growth factor receptor family in neoplasia: an update , 2012, Nature Reviews Cancer.

[48]  H. Anton-Culver,et al.  Body size and the risk of postmenopausal breast cancer subtypes in the California Teachers Study cohort , 2012, Cancer Causes & Control.

[49]  Amy Y. Chen,et al.  Prospective Studies of Body Mass Index with Head and Neck Cancer Incidence and Mortality , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[50]  廣畑 富雄,et al.  Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective , 2007 .

[51]  I. Gram,et al.  Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study , 2012, Breast Cancer Research.

[52]  C. Fox,et al.  Ectopic Fat Depots and Cardiovascular Disease , 2011, Circulation.

[53]  T. Byers,et al.  Does intentional weight loss reduce cancer risk? , 2011, Diabetes, obesity & metabolism.

[54]  B. Spiegelman,et al.  Molecular mechanisms of cancer development in obesity , 2011, Nature Reviews Cancer.

[55]  Goutham Rao,et al.  Assessing adiposity: a scientific statement from the American Heart Association. , 2011, Circulation.

[56]  S. Larsson,et al.  Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies. , 2011, European journal of cancer.

[57]  L. Joosten,et al.  Inflammasome is a central player in the induction of obesity and insulin resistance , 2011, Proceedings of the National Academy of Sciences.

[58]  Christian Gieger,et al.  Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile , 2011, Nature Genetics.

[59]  S. Daniels,et al.  Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease: Mechanistic, Research, and Clinical Considerations for Youth A Scientific Statement From the American Heart Association , 2011, Circulation.

[60]  M. McArthur,et al.  Genetic Reduction of Insulin-like Growth Factor-1 Mimics the Anticancer Effects of Calorie Restriction on Cyclooxygenase-2–Driven Pancreatic Neoplasia , 2011, Cancer Prevention Research.

[61]  A. Bosy-Westphal,et al.  Associations between breast adipose tissue, body fat distribution and cardiometabolic risk in women: cross-sectional data and weight-loss intervention , 2011, European Journal of Clinical Nutrition.

[62]  A. Renehan.  Height and cancer: consistent links, but mechanisms unclear. , 2011, The Lancet. Oncology.

[63]  Jonathan E. Dickerson,et al.  Supplementary webappendix , 2018 .

[64]  E. Giovannucci,et al.  Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs. , 2011, Gastroenterology.

[65]  R. Prentice,et al.  Body Size, Physical Activity, and Risk of Triple-Negative and Estrogen Receptor–Positive Breast Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[66]  M. García-Closas,et al.  The Obesity-Associated Polymorphisms FTO rs9939609 and MC4R rs17782313 and Endometrial Cancer Risk in Non-Hispanic White Women , 2011, PloS one.

[67]  W. Willett,et al.  Body fat distribution and risk of premenopausal breast cancer in the Nurses' Health Study II. , 2011, Journal of the National Cancer Institute.

[68]  K. Walsh,et al.  Adipokines in inflammation and metabolic disease , 2011, Nature Reviews Immunology.

[69]  N. Fuente,et al.  Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies , 2011 .

[70]  P. Clayton,et al.  Growth hormone, the insulin-like growth factor axis, insulin and cancer risk , 2011, Nature Reviews Endocrinology.

[71]  D. Leroith.  Can endogenous hyperinsulinaemia explain the increased risk of cancer development and mortality in type 2 diabetes: evidence from mouse models , 2010, Diabetes/metabolism research and reviews.

[72]  M. Zwahlen,et al.  Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[73]  K. McGlynn,et al.  A systematic review and meta-analysis of the relationship between body size and testicular cancer , 2010, British Journal of Cancer.

[74]  Jenny Donovan,et al.  Associations between an Obesity Related Genetic Variant (FTO rs9939609) and Prostate Cancer Risk , 2010, PloS one.

[75]  J. Murabito,et al.  Periaortic Fat Deposition Is Associated With Peripheral Arterial Disease: The Framingham Heart Study , 2010, Circulation. Cardiovascular imaging.

[76]  Udo Hoffmann,et al.  Prevalence, Distribution, and Risk Factor Correlates of High Pericardial and Intrathoracic Fat Depots in the Framingham Heart Study , 2010, Circulation. Cardiovascular imaging.

[77]  J. Cerhan,et al.  Body Size and Incident Colorectal Cancer: A Prospective Study of Older Women , 2010, Cancer Prevention Research.

[78]  F. Clavel-Chapelon,et al.  Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition. , 2010, American journal of epidemiology.

[79]  A. Renehan.  Obesity and cancer in Asia-Pacific populations. , 2010, The Lancet. Oncology.

[80]  P. Valet,et al.  Unraveling the obesity and breast cancer links: a role for cancer-associated adipocytes? , 2010, Endocrine development.

[81]  J. Visvader,et al.  Control of mammary stem cell function by steroid hormone signalling , 2010, Nature.

[82]  J. Tuomilehto,et al.  Diabetes, prediabetes and cancer mortality , 2010, Diabetologia.

[83]  S. Bakker,et al.  MRI-determined fat content of human liver, pancreas and kidney. , 2010, World journal of gastroenterology.

[84]  C. Ulrich,et al.  Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. , 2010, Journal of the National Cancer Institute.

[85]  G. Davey Smith,et al.  Supplementary Tables , 2009 .

[86]  J. Cuzick,et al.  Increase in Serum Total IGF-I and Maintenance of Free IGF-I Following Intentional Weight Loss in Pre-menopausal Women at Increased Risk of Breast Cancer , 2010 .

[87]  Jun Hee Lee,et al.  Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression , 2010, Cell.

[88]  C. Dive,et al.  Biological mechanisms linking obesity and cancer risk: new perspectives. , 2010, Annual review of medicine.

[89]  Tanya M. Teslovich,et al.  Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index , 2010 .

[90]  C. Koebnick,et al.  Height, body mass index, and physical activity in relation to glioma risk. , 2009, Cancer research.

[91]  F. Visseren,et al.  Obesity and Cancer: The Role of Dysfunctional Adipose Tissue , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[92]  B. S. Mohammed,et al.  Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity , 2009, Proceedings of the National Academy of Sciences.

[93]  A. Renehan.  Bariatric surgery, weight reduction, and cancer prevention. , 2009, The Lancet. Oncology.

[94]  M. Schulze,et al.  Anthropometry and Esophageal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition , 2009, Cancer Epidemiology Biomarkers & Prevention.

[95]  M. Pike,et al.  American Journal of Epidemiology Original Contribution Breast Cancer Risk Factors Defined by Estrogen and Progesterone Receptor Status the Multiethnic Cohort Study , 2022 .

[96]  A. Heagerty,et al.  Local Inflammation and Hypoxia Abolish the Protective Anticontractile Properties of Perivascular Fat in Obese Patients , 2009, Circulation.

[97]  R. Russell,et al.  Nonalcoholic steatohepatitis induced by a high‐fat diet promotes diethylnitrosamine‐initiated early hepatocarcinogenesis in rats , 2009, International journal of cancer.

[98]  Christian Trautwein,et al.  Inflammatory Pathways in Liver Homeostasis and Liver Injury , 2009, Clinical reviews in allergy & immunology.

[99]  A. Wolk,et al.  Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—A meta‐analysis , 2009, International journal of cancer.

[100]  A. Tenesa,et al.  Common genetic variants at the MC4R locus are associated with obesity, but not with dietary energy intake or colorectal cancer in the Scottish population , 2009, International Journal of Obesity.

[101]  E. Ponce,et al.  World Cancer Research Fund, American Institute for Cancer Research. Second Expert Report, Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. United Kingdom: WCRF/AICR, 2001 , 2009 .

[102]  G. Hotamisligil,et al.  Nutrient sensing and inflammation in metabolic diseases , 2008, Nature Reviews Immunology.

[103]  T. Erlinger,et al.  C‐reactive protein and colorectal cancer risk: A systematic review of prospective studies , 2008, International journal of cancer.

[104]  X. Shu,et al.  The modifying effect of C‐reactive protein gene polymorphisms on the association between central obesity and endometrial cancer risk , 2008, Cancer.

[105]  C. Koebnick,et al.  Body Mass Index, Physical Activity, and Bladder Cancer in a Large Prospective Study , 2008, Cancer Epidemiology Biomarkers & Prevention.

[106]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[107]  Norbert Stefan,et al.  Causes and metabolic consequences of Fatty liver. , 2008, Endocrine reviews.

[108]  N. Timpson,et al.  Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization , 2008, Annals of medicine.

[109]  A. Renehan.  Hormone, Growth Factors and Tumor Growth. , 2008 .

[110]  C. Dive,et al.  Obesity and cancer: Pathophysiological and biological mechanisms , 2008, Archives of physiology and biochemistry.

[111]  Iain Buchan,et al.  Body Fat Distribution and Risk of Coronary Heart Disease in Men and Women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk Cohort: A Population-Based Prospective Study , 2007, Circulation.

[112]  J. Palmer,et al.  A Prospective Study of Body Size and Breast Cancer in Black Women , 2007, Cancer Epidemiology Biomarkers & Prevention.

[113]  D. Rose,et al.  Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. , 2007, Endocrine-related cancer.

[114]  E. Giovannucci,et al.  The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. , 2007, Gastroenterology.

[115]  P. Fischer-Posovszky,et al.  Endocrinology of Adipose Tissue - An Update , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[116]  X. Shu,et al.  Polymorphisms in the CYP19A1 (Aromatase) Gene and Endometrial Cancer Risk in Chinese Women , 2007, Cancer Epidemiology Biomarkers & Prevention.

[117]  J. Schölmerich,et al.  Mechanisms of Disease: adipokines and breast cancer—endocrine and paracrine mechanisms that connect adiposity and breast cancer , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[118]  C. Vinson,et al.  The obesity-cancer link: lessons learned from a fatless mouse. , 2007, Cancer research.

[119]  T. T. Have,et al.  An introduction to causal modeling in clinical trials , 2007, Clinical trials.

[120]  D. Albanes,et al.  Adiposity, adult weight change, and postmenopausal breast cancer risk. , 2006, Archives of internal medicine.

[121]  D. Spiegelman,et al.  Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. , 2006, Journal of the National Cancer Institute.

[122]  A. Wolk,et al.  Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study , 2006, International journal of cancer.

[123]  A. Renehan,et al.  Obesity and cancer risk: the role of the insulin–IGF axis , 2006, Trends in Endocrinology & Metabolism.

[124]  C. Friedenreich,et al.  Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). , 2006, Journal of the National Cancer Institute.

[125]  J. Mckinlay,et al.  Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study , 2006, Clinical endocrinology.

[126]  M. Thun,et al.  Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women , 2006, Cancer.

[127]  J. Robins,et al.  Instruments for Causal Inference: An Epidemiologist's Dream? , 2006, Epidemiology.

[128]  M. Dieudonné,et al.  Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. , 2006, Biochemical and biophysical research communications.

[129]  D. English,et al.  Circulating Steroid Hormones and the Risk of Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[130]  E. Giovannucci,et al.  Are Findings from Studies of Obesity and Prostate Cancer Really in Conflict? , 2006, Cancer Causes & Control.

[131]  J. Chang-Claude,et al.  Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. , 2005, Endocrine-related cancer.

[132]  J. Chang-Claude,et al.  Serum Sex Steroids in Premenopausal Women and Breast Cancer Risk Within the European Prospective Investigation into Cancer and Nutrition (EPIC) , 2005 .

[133]  W. Willett,et al.  Sex Steroid Hormones and the Androgen Receptor Gene CAG Repeat and Subsequent Risk of Prostate Cancer in the Prostate-Specific Antigen Era , 2005, Cancer Epidemiology Biomarkers & Prevention.

[134]  C. Hankey,et al.  Relationships between cigarette smoking, body size and body shape , 2005, International Journal of Obesity.

[135]  Christopher F. Martin,et al.  Diet, Lifestyle, and Genomic Instability in the North Carolina Colon Cancer Study , 2005, Cancer Epidemiology Biomarkers & Prevention.

[136]  P. Brown,et al.  The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer , 2004, Breast Cancer Research.

[137]  F. Clavel-Chapelon,et al.  Body size and breast cancer risk: Findings from the European prospective investigation into cancer and nutrition (EPIC) , 2004, International journal of cancer.

[138]  J. Robins,et al.  A Structural Approach to Selection Bias , 2004, Epidemiology.

[139]  D. Rose,et al.  Obesity, adipocytokines, and insulin resistance in breast cancer , 2004, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[140]  E. Calle,et al.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.

[141]  K. Machens,et al.  Estrogen plus progestin and colorectal cancer in postmenopausal women. , 2004, The New England journal of medicine.

[142]  Matthias Egger,et al.  Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.

[143]  M. Singer,et al.  BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults , 2004, International Journal of Obesity.

[144]  T. Erlinger,et al.  C-reactive protein and the risk of incident colorectal cancer. , 2004, JAMA.

[145]  S. Ebrahim,et al.  Mendelian randomization: prospects, potentials, and limitations. , 2004, International journal of epidemiology.

[146]  E. Giovannucci.  Insulin and colon cancer , 1995, Cancer Causes & Control.

[147]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[148]  S. Cummings,et al.  Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. , 2003, Journal of the National Cancer Institute.

[149]  T. Key,et al.  Oestrogen exposure and breast cancer risk , 2003, Breast Cancer Research.

[150]  Michael M Lieber,et al.  The influence of finasteride on the development of prostate cancer. , 2003, The New England journal of medicine.

[151]  M. Cnop,et al.  Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex , 2003, Diabetologia.

[152]  R. Kaaks,et al.  Obesity , Endogenous Hormones , and Endometrial Cancer Risk : A Synthetic Review 1 , 2002 .

[153]  G. Bray.  The underlying basis for obesity: relationship to cancer. , 2002, The Journal of nutrition.

[154]  R. Paschke,et al.  Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. , 2002, Biochemical and biophysical research communications.

[155]  M. Leppert,et al.  Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. , 2000, Journal of the National Cancer Institute.

[156]  T. Sellers,et al.  Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study. , 2000, Archives of internal medicine.

[157]  B Rosner,et al.  Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study. , 1999, American journal of epidemiology.

[158]  J. Després,et al.  Obesity and Insulin Resistance , 1999 .

[159]  E. Riboli,et al.  Breast‐cancer incidence in relation to height, weight and body‐fat distribution in the Dutch “DOM” cohort , 1998, International journal of cancer.

[160]  G A Colditz,et al.  Dual effects of weight and weight gain on breast cancer risk. , 1997, JAMA.

[161]  I. Hay,et al.  Clinical Endocrine Oncology , 1997 .

[162]  Claude Bouchard,et al.  Handbook of obesity , 1997 .

[163]  J. Cerhan,et al.  Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[164]  G. McKeown-Eyssen.  Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[165]  J. V. Bokhman.  Two pathogenetic types of endometrial carcinoma. , 1983, Gynecologic oncology.